|

Recombinant Human Interleukin-2 Injections Clinical Trials

1 actively recruiting trial

Also known as: Monotherapy Group

Pipeline

Phase 2: 1

Top Sponsors

  • The First Affiliated Hospital of Xiamen University1

Indications

  • Lymphocytopenia1
  • Hematological Malignancy1
  • Cancer1

Other1 trial

Thymalfasin and Recombinant Human IL-2 Injections in Treating Lymphocytopenia for Patients With Malignant Hematological Tumors
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.